The companies have teamed to develop an alternative to TAVR that combines the benefits of a less-invasive procedure with the ...

Medtronic (NYSE: MDT) today announced the launch of its Stedi extra support guidewire for use with its Evolut TAVR platform.

Edwards Lifesciences (NYSE: EW) today announced seven-year data from the PARTNER 3 trial, reaffirming the early and sustained patient benefits of Edwards TAVR. The data, which showed superior clinical ...

Investing.com -- Edwards Lifesciences (NYSE:EW) stock rose 4.5% following the presentation of new data showing long-term benefits and valve performance of its SAPIEN 3 TAVR.

The data are largely in line with those seen at 5 years, but the follow-up reassures there’s no concern about valve ...

Emboline, Inc., a leading innovator in full-body embolic protection devices for transcatheter procedures, today announced completion of patient enrollment in its Protect the Head to Head (ProtectH2H) ...

In July, CMS proposed a significant expansion of the covered procedures list for ASCs, which included many cardiovascular procedures. Here’s what five leaders have said about the expansion of ...

Using a catheter to repair or replace a valve is a fairly recent breakthrough in the world of interventional cardiology. Early on, it was a procedure reserved largely for patients with a faulty aortic ...

Expanding your horizons and considering neglected sectors can help you identify bargain opportunities while defending your ...

Get Yashoda Hospitals News on Telangana Today, Yashoda Hospitals latest news, Yashoda Hospitals news, | Telangana Today ...

Texas Health Presbyterian Hospital Plano has officially begun a major new chapter in its growth. On Oct. 21, hospital leaders ...

Five-year data from the PARTNER 3 trial showed that among low-risk patients with severe, symptomatic aortic stenosis, ...